The SUMO-specific isopeptidase SENP3 regulates MLL1/MLL2 methyltransferase complexes and controls osteogenic differentiation

Molecular Cell

Volumn 55, Issue 1, 2014, Pages 47-58

  Nayak, Arnab ^a   Viale Bouroncle, Sandra ^b   Morsczeck, Christian ^b   Muller, Stefan ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; HISTONE METHYLTRANSFERASE; METHIONINE; PEPTIDASE; PROTEIN ASH2L; PROTEIN DPY 30; PROTEIN MLL1; PROTEIN MLL2; PROTEIN RBBP5; PROTEIN SENP3; PROTEIN WDR5; REGULATOR PROTEIN; RNA POLYMERASE II; SUMO PROTEIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CELL DIFFERENTIATION; COMPLEX FORMATION; CONTROLLED STUDY; DLX3 GENE; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION; GENE LOCUS; GENETIC REGULATION; HISTONE METHYLATION; HOX GENE; HUMAN; HUMAN CELL; OSTEOBLAST; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATOR GENE; REGULATORY MECHANISM; STEM CELL; SUMOYLATION;

CELL DIFFERENTIATION; CYSTEINE ENDOPEPTIDASES; DENTAL SAC; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HELA CELLS; HOMEODOMAIN PROTEINS; HUMANS; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OSTEOGENESIS; PROTO-ONCOGENE PROTEINS; STEM CELLS; TRANSCRIPTION FACTORS;

EID: 84903761891     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2014.05.011     Document Type: Article

References (68)

1. Alharbi R.A., Pettengell R., Pandha H.S., Morgan R. The role ofHOX genes in normal hematopoiesis and acute leukemia. Leukemia 2013, 27:1000-1008.
2. Avdic V., Zhang P., Lanouette S., Groulx A., Tremblay V., Brunzelle J., Couture J.F. Structural and biochemical insights into MLL1 core complex assembly. Structure 2011, 19:101-108.
3. Cao F., Chen Y., Cierpicki T., Liu Y., Basrur V., Lei M., Dou Y. An Ash2L/RbBP5 heterodimer stimulates the MLL1 methyltransferase activity through coordinated substrate interactions with the MLL1 SET domain. PLoS ONE 2010, 5:e14102.
4. Chen Y., Cao F., Wan B., Dou Y., Lei M. Structure of the SPRY domain of human Ash2L and its interactions with RbBP5 and DPY30. Cell Res. 2012, 22:598-602.
5. Choi S.J., Roodman G.D., Feng J.Q., Song I.S., Amin K., Hart P.S., Wright J.T., Haruyama N., Hart T.C. Invivo impact of a 4bp deletion mutation in the DLX3 gene on bone development. Dev. Biol. 2009, 325:129-137.
6. Choi S.J., Song I.S., Feng J.Q., Gao T., Haruyama N., Gautam P., Robey P.G., Hart T.C. Mutant DLX 3 disrupts odontoblast polarization and dentin formation. Dev. Biol. 2010, 344:682-692.
7. Couture J.F., Collazo E., Trievel R.C. Molecular recognition of histone H3 by the WD40 protein WDR5. Nat. Struct. Mol. Biol. 2006, 13:698-703.
8. Cubeñas-Potts C., Matunis M.J. SUMO: a multifaceted modifier of chromatin structure and function. Dev. Cell 2013, 24:1-12.
9. Denissov S., Hofemeister H., Marks H., Kranz A., Ciotta G., Singh S., Anastassiadis K., Stunnenberg H.G., Stewart A.F. Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant. Development 2014, 141:526-537.
10. Dou Y., Milne T.A., Tackett A.J., Smith E.R., Fukuda A., Wysocka J., Allis C.D., Chait B.T., Hess J.L., Roeder R.G. Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. Cell 2005, 121:873-885.
11. Dou Y., Milne T.A., Ruthenburg A.J., Lee S., Lee J.W., Verdine G.L., Allis C.D., Roeder R.G. Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat. Struct. Mol. Biol. 2006, 13:713-719.
12. Duboule D. The rise and fall of Hox gene clusters. Development 2007, 134:2549-2560.
13. Duverger O., Zah A., Isaac J., Sun H.W., Bartels A.K., Lian J.B., Berdal A., Hwang J., Morasso M.I. Neural crest deletion of Dlx3 leads to major dentin defects through down-regulation of Dspp. J.Biol. Chem. 2012, 287:12230-12240.
14. Duverger O., Isaac J., Zah A., Hwang J., Berdal A., Lian J.B., Morasso M.I. Invivo impact of Dlx3 conditional inactivation in neural crest-derived craniofacial bones. J.Cell. Physiol. 2013, 228:654-664.
15. Eklund E. The role of Hox proteins in leukemogenesis: insights into key regulatory events in hematopoiesis. Crit. Rev. Oncog. 2011, 16:65-76.
16. Ernst P., Vakoc C.R. WRAD: enabler of the SET1-family of H3K4 methyltransferases. Brief Funct Genomics 2012, 11:217-226.
17. Feng Z.J., Gurung B., Jin G.H., Yang X.L., Hua X.X. SUMO modification of menin. Am J Cancer Res 2013, 3:96-106.
18. Finkbeiner E., Haindl M., Muller S. The SUMO system controls nucleolar partitioning of a novel mammalian ribosome biogenesis complex. EMBO J. 2011, 30:1067-1078.
19. Gareau J.R., Lima C.D. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat. Rev. Mol. Cell Biol. 2010, 11:861-871.
20. Gavalas A., Ruhrberg C., Livet J., Henderson C.E., Krumlauf R. Neuronal defects in the hindbrain of Hoxa1, Hoxb1 and Hoxb2 mutants reflect regulatory interactions among these Hox genes. Development 2003, 130:5663-5679.
21. Gerasimova T.I., Corces V.G. Polycomb and trithorax group proteins mediate the function of a chromatin insulator. Cell 1998, 92:511-521.
22. Gregory C.A., Gunn W.G., Peister A., Prockop D.J. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal. Biochem. 2004, 329:77-84.
23. Haindl M., Harasim T., Eick D., Muller S. The nucleolar SUMO-specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing. EMBO Rep. 2008, 9:273-279.
24. Hassan M.Q., Javed A., Morasso M.I., Karlin J., Montecino M., van Wijnen A.J., Stein G.S., Stein J.L., Lian J.B. Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene. Mol. Cell. Biol. 2004, 24:9248-9261.
25. Hassan M.Q., Tare R., Lee S.H., Mandeville M., Weiner B., Montecino M., van Wijnen A.J., Stein J.L., Stein G.S., Lian J.B. HOXA10 controls osteoblastogenesis by directly activating bone regulatory and phenotypic genes. Mol. Cell. Biol. 2007, 27:3337-3352.
26. Hickey C.M., Wilson N.R., Hochstrasser M. Function and regulation of SUMO proteases. Nat. Rev. Mol. Cell Biol. 2012, 13:755-766.
27. Hu D., Garruss A.S., Gao X., Morgan M.A., Cook M., Smith E.R., Shilatifard A. The Mll2 branch of the COMPASS family regulates bivalent promoters in mouse embryonic stem cells. Nat. Struct. Mol. Biol. 2013, 20:1093-1097.
28. Huang C., Han Y., Wang Y., Sun X., Yan S., Yeh E.T., Chen Y., Cang H., Li H., Shi G., et al. SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation. EMBO J. 2009, 28:2748-2762.
29. Kang X., Qi Y., Zuo Y., Wang Q., Zou Y., Schwartz R.J., Cheng J., Yeh E.T. SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development. Mol. Cell 2010, 38:191-201.
30. Lee T.I., Jenner R.G., Boyer L.A., Guenther M.G., Levine S.S., Kumar R.M., Chevalier B., Johnstone S.E., Cole M.F., Isono K., et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 2006, 125:301-313.
31. Li H., Marijanovic I., Kronenberg M.S., Erceg I., Stover M.L., Velonis D., Mina M., Heinrich J.G., Harris S.E., Upholt W.B., et al. Expression and function of Dlx genes in the osteoblast lineage. Dev. Biol. 2008, 316:458-470.
32. Milne T.A., Briggs S.D., Brock H.W., Martin M.E., Gibbs D., Allis C.D., Hess J.L. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol. Cell 2002, 10:1107-1117.
33. Milne T.A., Hughes C.M., Lloyd R., Yang Z., Rozenblatt-Rosen O., Dou Y., Schnepp R.W., Krankel C., Livolsi V.A., Gibbs D., et al. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc. Natl. Acad. Sci. USA 2005, 102:749-754.
34. Morsczeck C., Götz W., Schierholz J., Zeilhofer F., Kühn U., Möhl C., Sippel C., Hoffmann K.H. Isolation of precursor cells (PCs) from human dental follicle of wisdom teeth. Matrix Biol. 2005, 24:155-165.
35. Mukhopadhyay D., Dasso M. Modification in reverse: the SUMO proteases. Trends Biochem. Sci. 2007, 32:286-295.
36. Nelson J.D., Denisenko O., Bomsztyk K. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat. Protoc. 2006, 1:179-185.
37. Ouyang J., Shi Y., Valin A., Xuan Y., Gill G. Direct binding ofCoREST1 to SUMO-2/3 contributes to gene-specific repression by the LSD1/CoREST1/HDAC complex. Mol. Cell 2009, 34:145-154.
38. Psakhye I., Jentsch S. Protein group modification and synergy inthe SUMO pathway as exemplified in DNA repair. Cell 2012, 151:807-820.
39. Raman N., Nayak A., Muller S. The SUMO system: a master organizer of nuclear protein assemblies. Chromosoma 2013, 122:475-485.
40. Ringrose L., Paro R. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu. Rev. Genet. 2004, 38:413-443.
41. Ruthenburg A.J., Wang W., Graybosch D.M., Li H., Allis C.D., Patel D.J., Verdine G.L. Histone H3 recognition and presentation by the WDR5 module of the MLL1 complex. Nat. Struct. Mol. Biol. 2006, 13:704-712.
42. Saugspier M., Felthaus O., Viale-Bouroncle S., Driemel O., Reichert T.E., Schmalz G., Morsczeck C. The differentiation and gene expression profile of human dental follicle cells. Stem Cells Dev. 2010, 19:707-717.
43. Schmidt D., Müller S. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc. Natl. Acad. Sci. USA 2002, 99:2872-2877.
44. Scholl C., Bansal D., Döhner K., Eiwen K., Huntly B.J., Lee B.H., Rücker F.G., Schlenk R.F., Bullinger L., Döhner H., et al. The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis. J.Clin. Invest. 2007, 117:1037-1048.
45. Schuettengruber B., Martinez A.M., Iovino N., Cavalli G. Trithorax group proteins: switching genes on and keeping them active. Nat. Rev. Mol. Cell Biol. 2011, 12:799-814.
46. Schuetz A., Allali-Hassani A., Martín F., Loppnau P., Vedadi M., Bochkarev A., Plotnikov A.N., Arrowsmith C.H., Min J. Structural basis for molecular recognition and presentation of histone H3 by WDR5. EMBO J. 2006, 25:4245-4252.
47. Sharov A.A., Ko M.S. Human ES cell profiling broadens the reach of bivalent domains. Cell Stem Cell 2007, 1:237-238.
48. Shilatifard A. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu. Rev. Biochem. 2012, 81:65-95.
49. Soshnikova N. Hox genes regulation in vertebrates. Dev. Dyn. 2014, 243:49-58.
50. Steward M.M., Lee J.S., O'Donovan A., Wyatt M., Bernstein B.E., Shilatifard A. Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes. Nat. Struct. Mol. Biol. 2006, 13:852-854.
51. Takechi M., Adachi N., Hirai T., Kuratani S., Kuraku S. The Dlx genes as clues to vertebrate genomics and craniofacial evolution. Semin. Cell Dev. Biol. 2013, 24:110-118.
52. Ullmann R., Chien C.D., Avantaggiati M.L., Muller S. An acetylation switch regulates SUMO-dependent protein interaction networks. Mol. Cell 2012, 46:759-770.
53. van der Veen A.G., Ploegh H.L. Ubiquitin-like proteins. Annu. Rev. Biochem. 2012, 81:323-357.
54. van Nuland R., Smits A.H., Pallaki P., Jansen P.W., Vermeulen M., Timmers H.T. Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes. Mol. Cell. Biol. 2013, 33:2067-2077.
55. Viale-Bouroncle S., Felthaus O., Schmalz G., Brockhoff G., Reichert T.E., Morsczeck C. The transcription factor DLX3 regulates the osteogenic differentiation of human dental follicle precursor cells. Stem Cells Dev. 2012, 21:1936-1947.
56. Wang P., Lin C., Smith E.R., Guo H., Sanderson B.W., Wu M., Gogol M., Alexander T., Seidel C., Wiedemann L.M., et al. Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II. Mol. Cell. Biol. 2009, 29:6074-6085.
57. Wilkinson K.A., Henley J.M. Mechanisms, regulation and consequences of protein SUMOylation. Biochem. J. 2010, 428:133-145.
58. Wysocka J., Swigut T., Milne T.A., Dou Y., Zhang X., Burlingame A.L., Roeder R.G., Brivanlou A.H., Allis C.D. WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Cell 2005, 121:859-872.
59. Yao S., Pan F., Prpic V., Wise G.E. Differentiation of stem cells inthe dental follicle. J.Dent. Res. 2008, 87:767-771.
60. Yeh E.T. SUMOylation and De-SUMOylation: wrestling with life's processes. J.Biol. Chem. 2009, 284:8223-8227.
61. Yokoyama A., Cleary M.L. Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell 2008, 14:36-46.
62. Yokoyama A., Somervaille T.C., Smith K.S., Rozenblatt-Rosen O., Meyerson M., Cleary M.L. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 2005, 123:207-218.
63. Yu B.D., Hess J.L., Horning S.E., Brown G.A., Korsmeyer S.J. Altered Hox expression and segmental identity in Mll-mutant mice. Nature 1995, 378:505-508.
64. Yu B.D., Hanson R.D., Hess J.L., Horning S.E., Korsmeyer S.J. MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morphogenesis. Proc. Natl. Acad. Sci. USA 1998, 95:10632-10636.
65. Yun C., Wang Y., Mukhopadhyay D., Backlund P., Kolli N., Yergey A., Wilkinson K.D., Dasso M. Nucleolar protein B23/nucleophosmin regulates the vertebrate SUMO pathway through SENP3 and SENP5 proteases. J.Cell Biol. 2008, 183:589-595.
66. Zakany J., Duboule D. The role of Hox genes during vertebrate limb development. Curr. Opin. Genet. Dev. 2007, 17:359-366.
67. Zhang P., Bergamin E., Couture J.F. The many facets of MLL1 regulation. Biopolymers 2013, 99:136-145.
68. Zhao X.D., Han X., Chew J.L., Liu J., Chiu K.P., Choo A., Orlov Y.L., Sung W.K., Shahab A., Kuznetsov V.A., et al. Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell 2007, 1:286-298.